| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | STA00D | |||
| Carrier Free | PDTA00D | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | SMLB00C | |||
| Carrier Free | PMLB00C | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | SS600C | |||
| Carrier Free | PHS600C | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | SB100C | |||
| Carrier Free | PDB100C | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | SKGE004B | |||
| Carrier Free | PKGE004B | |||
![N/A IL-6 [HRP]](http://images.novusbio.com/fullsize/elisa/DATA_IL6_M6000_ELISA_936.jpg "N/A IL-6 [HRP]")
![N/A IL-6 [HRP]](http://images.novusbio.com/fullsize/elisa/IL-6_M6000_ELISA_415.jpg)
![N/A VEGF [HRP]](http://images.novusbio.com/fullsize/elisa/DATA_VEGF_DVE00_ELISA_871.jpg "N/A VEGF [HRP]")
![N/A VEGF [HRP]](http://images.novusbio.com/fullsize/elisa/DATA_VEGF_DVE00_ELISA_872.jpg)
![N/A VEGF [HRP]](http://images.novusbio.com/fullsize/elisa/VEGF_DVE00_ELISA_208.jpg)
![N/A IL-19 [HRP]](http://images.novusbio.com/fullsize/elisa/dta00d_human-tnf-alpha-quantikine-pharmpak-50-plates-2672021102137.jpg "N/A IL-19 [HRP]")
![N/A IL-19 [HRP]](http://images.novusbio.com/fullsize/elisa/dta00d_human-tnf-alpha-quantikine-pharmpak-50-plates-2672021102236.jpg)
![N/A IL-1 beta/IL-1F2 [HRP]](http://images.novusbio.com/fullsize/elisa/DATA_IL1_beta_MLB00_ELISA_994.jpg "N/A IL-1 beta/IL-1F2 [HRP]")
![N/A IL-1 beta/IL-1F2 [HRP]](http://images.novusbio.com/fullsize/elisa/IL1_beta_MLB00_ELISA_425.jpg)
![N/A IL-6 [HRP]](http://images.novusbio.com/fullsize/elisa/hs600c_human-il-6-quantikine-hs-sixpak-6-plates-148202014493.jpg "N/A IL-6 [HRP]")
![N/A IL-6 [HRP]](http://images.novusbio.com/fullsize/elisa/hs600c_human-il-6-quantikine-hs-sixpak-6-plates-1482020145254.jpg)
![N/A CXCL8/IL-8 [HRP]](http://images.novusbio.com/fullsize/elisa/DATA_CXCL8_IL8_D8050_ELISA_557.jpg "N/A CXCL8/IL-8 [HRP]")
![N/A CXCL8/IL-8 [HRP]](http://images.novusbio.com/fullsize/elisa/DATA_CXCL8_IL8_D8050_ELISA_558.jpg)
![N/A CXCL8/IL-8 [HRP]](http://images.novusbio.com/fullsize/elisa/CXCL8_D8000C_ELISA_378.jpg)
![Toll-like receptor 4 (TLR4) silencing decreases endogenous levels of pro-inflammatory cytokines. a Effect of TLR2/4 silencing in breast cancer cells transfected with negative control (nc) siRNA, or siRNA directed against TLR2 mRNA (si#1 and si#2) or TLR4 mRNA (si#1 and si#2) was analyzed using quantitative real-time PCR; ***P <0.001 (analysis of variance (ANOVA)). b IL-6 (left) and IL-8 (right) ELISA on supernatants from MDA-MB-231 breast cancer cells transfected with nc siRNA, or siRNA directed against TLR2 mRNA (si#1 and si#2) or TLR4 mRNA (si#1 and si#2); n = 4. Error bars standard error of the mean (SEM); *P <0.05, **P <0.01, ***P <0.001 (ANOVA). c Boyden chamber migration assays. Migration of primary human myeloid cells towards supernatants from different cell lines indicated. Human primary peripheral blood mononuclear cells were isolated as previously described [48] and allowed to migrate through a Costar Transwell® Permeable Support 8.0-μm 24-well plate (Corning) to the supernatants of breast cancer supernatants cultured under serum-free conditions. Percentage of migrated CD11b+ cells was analyzed using a flow cytometer and CD11b-APC antibodies (BD Sciences); n = 4. Error bars SEM; *P <0.05, **P <0.01, ***P <0.001 (ANOVA). d Matrigel invasion assays. Invasion of lipopolysaccharide (LPS)-stimulated/un-stimulated MDA-MB-231 cells into matrigel invasion chambers (BD Sciences) as indicated: 25 × 103 MDA-MB-231 cells were stimulated or not with LPS and allowed to invade from 72 h. Amount of invaded cells was analyzed using crystal violet staining and manual counting in four separate experiments; n = 4. Error bars SEM; *P <0.05, **P <0.01, ***P <0.001 (Student’s t test) Image collected and cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/26392082), licensed under a CC-BY license. Not internally tested by R&D Systems.](http://images.novusbio.com/fullsize/d8000c_human-il-8-cxcl8-quantikine-elisa-kit-22820241795613.jpg)
![N/A TGF-beta 1 [HRP]](http://images.novusbio.com/fullsize/elisa/db100c_human-tgf-beta-1-quantikine-sixpak-6-plates-98202194716.jpg "N/A TGF-beta 1 [HRP]")
![N/A TGF-beta 1 [HRP]](http://images.novusbio.com/fullsize/elisa/db100c_human-tgf-beta-1-quantikine-sixpak-6-plates-98202194825.jpg)
![N/A TGF-beta 1 [HRP]](http://images.novusbio.com/fullsize/elisa/db100c_human-tgf-beta-1-quantikine-sixpak-6-plates-98202194957.jpg)
![N/A Prostaglandin E2/PGE2 [Biotin]](http://images.novusbio.com/fullsize/elisa/DATA_PGE2_KGE004_ELISA_906.jpg "N/A Prostaglandin E2/PGE2 [Biotin]")
![N/A Prostaglandin E2/PGE2 [Biotin]](http://images.novusbio.com/fullsize/elisa/PGE2_KGE004_ELISA_406.jpg)
![N/A IL-1 beta/IL-1F2 [HRP]](http://images.novusbio.com/fullsize/elisa/DATA_IL1_beta_DLB50_ELISA_738.jpg "N/A IL-1 beta/IL-1F2 [HRP]")
![N/A IL-1 beta/IL-1F2 [HRP]](http://images.novusbio.com/fullsize/elisa/DATA_IL1_beta_DLB50_ELISA_739.jpg)
![N/A IL-1 beta/IL-1F2 [HRP]](http://images.novusbio.com/fullsize/elisa/IL-1_beta_DLB50_ELISA_129.jpg)
![Immunoplate for neural derived exosome isolation (Colorimetric) [NBP3-14803] - Plate is selective in capturing purified exosomes (pellet after centrifugation 120000g) and no other circulating microvesicle (pellet 1200g and 10000g).](http://images.novusbio.com/fullsize/nbp3-14803_immunoplate-for-neural-derived-exosome-isolation-color-1612202412502214.png "Immunoplate for neural derived exosome isolation (Colorimetric) [NBP3-14803] - Plate is selective in capturing purified exosomes (pellet after centrifugation 120000g) and no other circulating microvesicle (pellet 1200g and 10000g).")
![Immunoplate for neural derived exosome isolation (Colorimetric) [NBP3-14803] - Comparison of CD9 detection on purified (ultracentrifuged) plasma exosomes vs unfractionated samples in a set of healthy donor’s plasma.](http://images.novusbio.com/fullsize/nbp3-14803_immunoplate-for-neural-derived-exosome-isolation-color-161220241250229.png)
![Immunoplate for neural derived exosome isolation (Colorimetric) [NBP3-14803] - CD63 profiling on exosomes derived from supernatants of different cell lines.](http://images.novusbio.com/fullsize/nbp3-14803_immunoplate-for-neural-derived-exosome-isolation-color-1612202412502219.png)
![Immunoplate for neural derived exosome isolation (Colorimetric) [NBP3-14803] - Common exosomal biomarkers analysis in a healthy donor’s plasma sample.](http://images.novusbio.com/fullsize/nbp3-14803_immunoplate-for-neural-derived-exosome-isolation-color-161220241250226.png)
![Immunoplate for neural derived exosome isolation (Colorimetric) [NBP3-14803] - Specific immunocapture of 30 μg of exosome isolated from Neuroblastoma (SH-30) or Glioblastoma (U87-30) cell lines in specific immunoplates. COLO cell and plasma (PEP) purified exosomes were used as controls.](http://images.novusbio.com/fullsize/nbp3-14803_immunoplate-for-neural-derived-exosome-isolation-color-17122024152630..png)
![Immunoplate for neural derived exosome isolation (Colorimetric) [NBP3-14803] - Immunocapture of neuroblastoma derived exosomes (SH) subpopulation diluted in human plasma from healthy donors.](http://images.novusbio.com/fullsize/nbp3-14803_immunoplate-for-neural-derived-exosome-isolation-color-17122024152757..png)
![Immunoplate for glial derived exosome isolation (Colorimetric) [NBP3-14802] - CD63 profiling on exosomes derived from supernatants of different cell lines.](http://images.novusbio.com/fullsize/nbp3-14802_immunoplate-for-glial-derived-exosome-isolation-color-161220241250225.png "Immunoplate for glial derived exosome isolation (Colorimetric) [NBP3-14802] - CD63 profiling on exosomes derived from supernatants of different cell lines.")
![Immunoplate for glial derived exosome isolation (Colorimetric) [NBP3-14802] - Comparison of CD9 detection on purified (ultracentrifuged) plasma exosomes vs unfractionated samples in a set of healthy donor’s plasma.](http://images.novusbio.com/fullsize/nbp3-14802_immunoplate-for-glial-derived-exosome-isolation-color-1612202412502213.png)
![Immunoplate for glial derived exosome isolation (Colorimetric) [NBP3-14802] - Common exosomal biomarkers analysis in a healthy donor’s plasma sample.](http://images.novusbio.com/fullsize/nbp3-14802_immunoplate-for-glial-derived-exosome-isolation-color-1612202412502215.png)
![Immunoplate for glial derived exosome isolation (Colorimetric) [NBP3-14802] - Plate is selective in capturing purified exosomes (pellet after centrifugation 120000g) and no other circulating microvesicle (pellet 1200g and 10000g).](http://images.novusbio.com/fullsize/nbp3-14802_immunoplate-for-glial-derived-exosome-isolation-color-161220241250221.png)
![Immunoplate for glial derived exosome isolation (Colorimetric) [NBP3-14802] - Specific immunocapture of 30 μg of exosome isolated from Neuroblastoma (SH-30) or Glioblastoma (U87-30) cell lines in specific immunoplates. COLO cell and plasma (PEP) purified exosomes were used as controls.](http://images.novusbio.com/fullsize/nbp3-14802_immunoplate-for-glial-derived-exosome-isolation-color-1712202415243..png)
![Immunoplate for glial derived exosome isolation (Colorimetric) [NBP3-14802] - Immunocapture of glioblastoma derived exosomes (U87) subpopulation diluted in human plasma from healthy donors.](http://images.novusbio.com/fullsize/nbp3-14802_immunoplate-for-glial-derived-exosome-isolation-color-17122024152535..png)
![Immunoplate for Tumor-derived Exosome Isolation (Colorimetric) [NBP3-14806] - Plate is selective in capturing purified exosomes (pellet after centrifugation 120000g) and no other circulating microvesicle (pellet 1200g and 10000g).](http://images.novusbio.com/fullsize/nbp3-14806_immunoplate-for-tumor-derived-exosome-isol-color-161220241250222.png "Immunoplate for Tumor-derived Exosome Isolation (Colorimetric) [NBP3-14806] - Plate is selective in capturing purified exosomes (pellet after centrifugation 120000g) and no other circulating microvesicle (pellet 1200g and 10000g).")
![Immunoplate for Tumor-derived Exosome Isolation (Colorimetric) [NBP3-14806] - Comparison of CD9 detection on purified (ultracentrifuged) plasma exosomes vs unfractionated samples in a set of healthy donor’s plasma.](http://images.novusbio.com/fullsize/nbp3-14806_immunoplate-for-tumor-derived-exosome-isol-color-1612202412502216.png)
![Immunoplate for Tumor-derived Exosome Isolation (Colorimetric) [NBP3-14806] - CD63 profiling on exosomes derived from supernatants of different cell lines.](http://images.novusbio.com/fullsize/nbp3-14806_immunoplate-for-tumor-derived-exosome-isol-color-1612202412502218.png)
![Immunoplate for Tumor-derived Exosome Isolation (Colorimetric) [NBP3-14806] - Common exosomal biomarkers analysis in a healthy donor’s plasma sample.](http://images.novusbio.com/fullsize/nbp3-14806_immunoplate-for-tumor-derived-exosome-isol-color-161220241250227.png)
![Immunoplate for Tumor-derived Exosome Isolation (Colorimetric) [NBP3-14806] - Immunoplate for tumor-derived exosomes capture allows discrimination of cancer patients (black arrows).](http://images.novusbio.com/fullsize/nbp3-14806_immunoplate-for-tumor-derived-exosome-isol-color-1712202415181..png)